BioSpace News Archive

Drug Development

Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2019 San Antonio Breast Cancer Symposium

A copy of this poster presentation is available on the Puma website

December 11, 2019
·
8 min read
Deals

Dentsply Sirona Declares Quarterly Cash Dividend - Dec. 11, 2019

DENTSPLY SIRONA Inc., The Dental Solutions Company™, announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share of common stock, an indicated annual rate of $0.40 per share.

December 11, 2019
·
1 min read
Biotech Bay

Livongo Announces Pricing of Public Offering by Selling Stockholders

Livongo will not receive any of the proceeds from the sale of the shares of its common stock being offered by the selling stockholders, and will bear the costs associated with the sale of such shares, other than underwriting discounts and commissions.

December 11, 2019
·
2 min read
Drug Development

Ocugen Announces Completion of 50% of Enrollment of its Phase 3 Clinical Trial for ocular GVHD

Topline data anticipated in second half of 2020

December 11, 2019
·
4 min read